FOR IMMEDIATE RELEASE
Contact: Joseph Fischer, President and CEO, Lifeblood Medical, Inc.
1.732.431.5877

LIFEBLOOD MEDICAL, INC. TO RECEIVE PRESTIGIOUS FROST & SULLIVAN INNOVATION AWARD AT NOVEMBER 12 HEALTHCARE EVENT

Adelphia, NJ - Monday November 10, 2008 - Based on its recent analysis of the North American market, Frost & Sullivan recognizes Lifeblood Medical, Inc. with the 2008 North American Pharmaceuticals & Biotechnology Emerging Healthcare Innovation Award. Lifeblood Medical will receive this award at the 2008 Excellence in Healthcare Innovation Awards Banquet, to be held November 12, 2008 in San Antonio, Texas.

"We are immensely proud of the recognition by Frost & Sullivan through the receipt of this award," said Lifeblood Medical President and CEO Joseph Fischer. "This prestigious Award recognizes Lifeblood Medical for its product innovation in organ transplant and preservation, and recognizes the company's ability to address a variety of markets that could expand its position in the industry and accelerate growth. We expect that receiving this award will expand the awareness of our dedication not only to improving organ preservation but also the welfare of the public at large by bringing innovative products to the life sciences industry."

The Company's unique, patented technology is based upon a nanoparticle solution which is animal-protein and animal-serum free. Numerous studies have proven the technology to preserve and regenerate organs for transplantation, culture and preserve stem cells, improve vaccine manufacturing, provide room-temperature preservation for the transportation of cells and tissues, and preserve limbs for reattachment.

"With Lifor, Lifeblood Medical has developed a product with capabilities and characteristics that stand out from other organ transplant products, both in the market and in visible development," says Frost & Sullivan Research Analyst Barath Shankar Subramanian. "By positioning itself in a high-profile and underserved area of organ transplant, through a highly innovative and flexible technology, Lifeblood Medical is at the forefront of product innovation in organ transplant and preservation."

About Frost & Sullivan
their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership™ empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnership Services, visit http://www.awards.frost.com.

About Lifeblood Medical, Inc.
Lifeblood Medical, Inc. is a leading innovator in providing GMP approved, animal-free and toxic-free component solutions for a wide range of applications in multiple healthcare markets. The Company draws upon its proprietary patented technology to address some of the world's most pressing issues in the fields of organ preservation, regenerative medicine and cell therapy. Lifeblood Medical, Inc.'s vision is to continue to develop novel solutions through our ability to preserve every cell in the human body.